Article
30 May 2023
It's Time To Change How Antibodies Are Claimed In Patent Strategy
AUTHORS CONTENT
Article
13 Mar 2023
USPTO Announces All Patent Term Extension Requests To Be Filed Electronically
Article
16 Apr 2021
Indefiniteness: Bad Translation/Lack Of Definition Redux
Article
08 Feb 2021
Two-Step Eligibility For Genomic Analysis Systems
Article
09 Dec 2020
What Is "About" All About?
Article
30 Sep 2020
When Are Recombinant Proteins Structurally Different Than Their Natural Counterparts?
Article
17 Sep 2020
USPTO Launches National Council For Expanding American Innovation
Article
27 Aug 2020
Certified Translation Of Italian Patent Loses Case For Pharma Company
Article
18 Aug 2020
Indefiniteness: Bad Translation, Lack Of Definition Or Both?
Article
29 Jul 2020
The Federal Circuit Provides A Refresher On Joint Inventorship
Article
28 May 2020
USPTO Launches "IP Marketplace" Related To COVID-19
Article
24 Oct 2019
The Flip Side Of Reasonable Expectation Of Success Is Unpredictability
Article
28 Aug 2019
Cannabis Patent Lawsuits Are Blazing—Why The Law Is So Hazy
Article
20 Aug 2019
Non-Limiting Clauses And Written Description Based On Substantially Equivalent Disclosure
Article
11 Jul 2019
Why Cannabis Patent Enforcement Is In The Weeds
Article
24 Jun 2019
"Statutory" Obviousness-Type Double Patenting for Pharma Patents?
Article
02 May 2019
"[T]He Proper Application Of The Supreme Court's Alice Standard Is An Evolving And Sometimes Hazy Area Of Law"
Article
28 Feb 2019
The Federal Circuit Stays The Course In Patent Ineligibility For An Abstract Idea
Article
30 Oct 2018
Written Description: Picking And Choosing And Blaze Marks
Article
11 Sep 2018
What Does And/Or Mean? It Depends